Clinical AI
Tempus AI Bets $1.5 Billion on Genomics Consolidation to Dominate Precision Oncology Market
Chicago-based diagnostics giant acquires Personalis in all-stock deal, merging AI-powered multimodal platforms with deep tumor sequencing to create end-to-end cancer profiling powerhouse.
Health AI Central Editorial Team·July 20, 2026